Drug-microbiome interactions: What we know and why predictive translation remains elusive

Area of Science:

• Microbiology
• Pharmacology
• Systems Biology

Background:

• Drug-induced gut microbiome alterations impact medication efficacy and toxicity.
• Current understanding of drug-microbe interactions has limited predictive clinical application.
• Static microbial profiles are insufficient due to context-dependent microbial activity.

Purpose of the Study:

• To highlight the limitations of current methods in predicting drug-microbiome interactions.
• To propose a new framework for translating drug-microbe research into clinical practice.
• To emphasize the need for functional and context-specific measurements.

Main Methods:

• Review of existing evidence on drug-microbe interactions.
• Analysis of factors influencing microbial activity in the gastrointestinal tract.
• Conceptual framework development for predictive modeling.

Main Results:

• Drug-microbiome interactions are complex and influenced by host factors (pH, transit time, nutrients).
• Predictive models based solely on taxonomic shifts or isolated assays are inadequate.
• Functional outputs, site-specific activity, and host context are critical for accurate prediction.

Conclusions:

• Translating drug-microbe interaction research into clinical practice requires a shift from static microbial properties to dynamic, functional, and context-specific measurements.
• Measuring functional outputs, ecological interactions, and host-contextual modulation is essential for predicting drug efficacy and toxicity.
• A systems-level approach integrating host and microbial factors is necessary for advancing personalized medicine.